TESTING PORE REFINING
daily application the placebo formulation had a mild negative effect on the volume of pores; the volume increased by 3.7%. Overall, the accumulated volume of the pores was reduced by up to 15.5% with CutiFine CLR.
At the end of the study, the volunteers were asked whether they agreed with the statement “My facial pores are less visible.” The results show that there is a satisfaction rate of 91.3% after having applied a cosmetic formulation with CutiFine CLR. This was 30.4% more than the satisfaction rate after application of the placebo formulation (identical but not containing CutiFine CLR).
CONCLUSIONS
The number of conspicuous pores on the skin treated with CutiFine CLR was reduced by 7.5% at 28 days into the study. This figure was increased to 11.7% after 56 days. The skin treated with the corresponding placebo formulation only showed a reduction of detectable pores by roughly 2% at both timepoints. These results show that CutiFine CLR can clearly reduce the number of conspicuous pores. In addition, the total surface area of the pores was also clearly reduced with
Figure 3 Reduction in accumulated volume of pores (%)
the formulation containing 3% CutiFine CLR. This trend already started after 28 days into the study, but continued after 56 days. The placebo formulation seems to have had a somewhat positive effect after 58 days as well, but was clearly outperformed by CutiFine CLR. Lastly, the accumulated total volume of the pores was determined. As was the case with circumference, with this parameter too, after 28 days of twice
Figure 4 Percentage of volunteers in agreement with the statement ‘my pores are less visible’
The number three main skin concern for women is visible pores. Up until now, the cosmetic industry has been unable to provide adequate solutions for this problem. This illustrates that astringents – ingredients which have historically been used for diminishing the visibility of pores by temporarily reducing their size – are not effective enough. There is a need for a solution – one which addresses all the aspects of visible pores, not only pore size but colour contrast as well, and which acts on those biological processes that take place deep inside the skin and its follicles leading to these issues. As elaborated on in this article, there are several facets to conspicuous pores. Pores become more visible because of a wide array of cell biological processes which have lost their natural equilibrium, where one problem can lead to another.
CutiFine CLR was developed to work at the core of the causes leading to this common problem with pores. It acts on all the most important features that make pores larger and lead to higher colour contrast.
CutiFine CLR acts on sebum production, barrier function, inflammation, free radicals, glycation, protein carbonylation, keratinocyte hyperproliferation and dermal structure. In the in vivo study which was performed, a clear and positive effect could be shown with CutiFine CLR, both as measured with AEVA-HE technology and, even more importantly, in the perception of the volunteers who took part in the study
Author Harald van der Hoeven, CLR
www.clr-berlin.com
46 June 2023
cosmeticsbusiness.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60
